Patents by Inventor Arthur Prindle

Arthur Prindle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11613758
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: March 28, 2023
    Assignees: The Regents of the University of California, Massachusetts Institute of Technology
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Publication number: 20220251579
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Application
    Filed: November 11, 2021
    Publication date: August 11, 2022
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Patent number: 11174486
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: November 16, 2021
    Assignees: The Regents of the University of California, Massachusetts Institute of Technology
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Patent number: 10908151
    Abstract: The present disclosure provides compositions comprising a food product, non-pathogenic microorganism, kits, methods of diagnosing a tumor in a subject, methods of quantifying the number of cancer cells in a cell sample, and methods of detecting a cancer cell, cancer tissue, or cell associated with a hyperproliferative disorder. In some embodiments, the method comprises a step of detecting the presence or absence of a modified substrate or portion thereof in urine of an animal without an instrument and solely by visual inspection of the urine.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: February 2, 2021
    Assignees: Massachusetts Institute of Technology, The Regents of the University of California
    Inventors: Tal Danino, Sangeeta N. Bhatia, Arthur Prindle, Jeff Hasty
  • Publication number: 20190250152
    Abstract: The present disclosure provides compositions comprising a food product, non-pathogenic microorganism, kits, methods of diagnosing a tumor in a subject, methods of quantifying the number of cancer cells in a cell sample, and methods of detecting a cancer cell, cancer tissue, or cell associated with a hyperproliferative disorder. In some embodiments, the method comprises a step of detecting the presence or absence of a modified substrate or portion thereof in urine of an animal without an instrument and solely by visual inspection of the urine.
    Type: Application
    Filed: January 28, 2019
    Publication date: August 15, 2019
    Inventors: Tal DANINO, Sangeeta N. Bhatia, Arthur Prindle, Jeff Hasty
  • Patent number: 10234449
    Abstract: The present disclosure provides compositions comprising a food product, non-pathogenic microorganism, kits, methods of diagnosing a tumor in a subject, methods of quantifying the number of cancer cells in a cell sample, and methods of detecting a cancer cell, cancer tissue, or cell associated with a hyperproliferative disorder. In some embodiments, the method comprises a step of detecting the presence or absence of a modified substrate or portion thereof in urine of an animal without an instrument and solely by visual inspection of the urine.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: March 19, 2019
    Assignees: Massachusetts Institute of Technology, The Regents of The University of California
    Inventors: Tal Danino, Sangeeta N. Bhatia, Arthur Prindle, Jeff Hasty
  • Publication number: 20180148729
    Abstract: Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.
    Type: Application
    Filed: April 7, 2016
    Publication date: May 31, 2018
    Inventors: Jeff Hasty, Lev Tsimring, Muhammad Omar Din, Arthur Prindle, Sangeeta Bhatia, Tal Danino
  • Patent number: 9500636
    Abstract: This invention provides a multiscale platform for coordinating behavior using synthetic biology. The platform reduces the impact of underlying noise, making outputs more coherent and reliable at the macroscopic level. In one aspect, the invention provides a frequency-modulated biosensor, comprising a microfluidic array comprising two or more separate colonies or populations of sensing cells to grow and communicate by gas exchange, wherein the colonies or populations of sensing cells output synchronized oscillating signals.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: November 22, 2016
    Assignee: The Regents of the University of California
    Inventors: Arthur Prindle, Phillip Samayoa, Jeff Hasty
  • Publication number: 20160033485
    Abstract: The present disclosure provides compositions comprising a food product, non-pathogenic microorganism, kits, methods of diagnosing a tumor in a subject, methods of quantifying the number of cancer cells in a cell sample, and methods of detecting a cancer cell, cancer tissue, or cell associated with a hyperproliferative disorder. In some embodiments, the method comprises a step of detecting the presence or absence of a modified substrate or portion thereof in urine of an animal without an instrument and solely by visual inspection of the urine.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 4, 2016
    Inventors: Tal Danino, Sangeeta N. Bhatia, Arthur Prindle, Jeff Hasty
  • Publication number: 20150133339
    Abstract: This invention provides a multiscale platform for coordinating behavior using synthetic biology. The platform reduces the impact of underlying noise, making outputs more coherent and reliable at the macroscopic level.
    Type: Application
    Filed: December 14, 2012
    Publication date: May 14, 2015
    Applicant: The Regents of the University of California
    Inventors: Arthur Prindle, Phillip Samayoa, Jeff Hasty